Interesting presentation Yesterday.
Share price 40 cents close to what I paid many moons ago.
However reference in the presentation;
"Partnering activities for the tigilanol tiglate human programme continued to progress with target companies."
Trails are open label I recall, so negotiations ongoing through these trials, should we have success in phase 2's I suspect offer for partnering licensing deal could be impressive, I would assume there would be a few options here to partner assuming assets any good.
Big Pahrma's looking to bolt on couple of assets could be game changing for us, licensing/partnering deal could bring large up front and do heavy lifting moving forward for phase 3's, ensuring speed to market, game changing for us....
Evidently this must be the bottom, surely the only way is up given our stage of development.
- Forums
- ASX - By Stock
- Qbiotics
Qbiotics, page-1160
Featured News
Featured News
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online